Sinopharm Group Co. Ltd.

1099

CNE100000FN7

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 04:08:22 2024-04-29 am EDT			5-day change	1st Jan Change
20.2 ^HKD	-6.26%		+1.61%	-1.22%

Apr. 29	Wall Street Cues, Property Outlooks Lift Asian Stock Markets	MT
Apr. 29	China, Hong Kong stocks rise, led by property shares	RE

Sinopharm Group Co. Ltd. Proposes Final Dividend of for the Financial Year Ended 31 December 2023, Payable on 13 August 2024

March 24, 2024 at 06:15 pm EDT

Sinopharm Group Co. Ltd. proposed final dividend of RMB 0.87 per share for the financial year ended 31 December 2023. Ex-dividend date: 17 June 2024.

Record date: 24 June 2024. Payment date: 13 August 2024. Date of shareholders' approval: 13 June 2024.

Latest news about Sinopharm Group Co. Ltd.

Wall Street Cues, Property Outlooks Lift Asian Stock Markets	Apr. 29	MT
China, Hong Kong stocks rise, led by property shares	Apr. 29	RE
Sinopharm Group Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Sinopharm Group Shares Fall as Higher Costs Cut Into Quarterly Profit	Apr. 28	DJ
Sinopharm Group's Q1 Profit Falls as Operating Costs Rise	Apr. 28	MT
Central Bank, Tech Outlooks Lift Major Asian Stock Markets	Apr. 26	MT
Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets	Apr. 16	MT
Chinese FDA Grants Marketing Approval for Shyndec Subsidiary's Drug Raw Materials	Apr. 10	MT
China Production Bases of Shyndec Pharmaceutical's Unit Gets Compliance Certification from Australian Regulator	Mar. 27	MT
Sinopharm's Attributable Profit Jumps in 2023 on Higher Revenue	Mar. 24	MT
Sinopharm Group Co. Ltd. Proposes Final Dividend of for the Financial Year Ended 31 December 2023, Payable on 13 August 2024	Mar. 24	CI
Sinopharm Group Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 24	CI
China Stocks Muted at Close as Recovery Optimism Fades; Sinopharm Jumps 6% on Upbeat 2023 Earnings	Mar. 21	MT
Sinopharm's 2023 Profit Climbs 9%; Shares Up 6%	Mar. 21	MT
US Inflation, Light News Flow Churns Asian Stock Markets	Mar. 13	MT
Sinopharm Group Co. Ltd. Announces Change of Registered Address	Mar. 12	CI
Nomura Adjusts Sinopharm Group’s Price Target to HK$32.39 Form HK$33.31, Keeps at Buy	Mar. 11	MT
China Traditional Chinese Medicine's Stock Bolts on Privatization Offer	Feb. 22	MT
China stocks extend gains led by coal, AI; HK shares up	Feb. 22	RE
Hong Kong Stocks Hover Near Two-Month Highs Amid Mixed Corporate Earnings	Feb. 22	MT
China stocks jump with AI shares leading on Nvidia forecast; HK shares flat	Feb. 21	RE
Sinopharm offers to take China-TCM private in nearly $3 bln deal	Feb. 21	RE
Shyndec Pharma Unit's Cefotaxime Sodium for Injection Passes Drug Regulator's Consistency Evaluation	Feb. 20	MT
Cancer Drug of Shyndec Pharma's Unit Passes Drug Regulator's Evaluation	Feb. 20	MT
Shyndec Pharma Unit Obtains Antihistamine Marketing Rights for 7.7 Million Yuan	Jan. 03	MT

Chart Sinopharm Group Co. Ltd.

Duration

Period

More charts

Sinopharm Group Co Ltd is a China-based company principally engaged in pharmaceutical and medical devices distribution business. The Company operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical devices, as well as provides installation and maintenance services. Retail Pharmacy segment is engaged in the operation of chain pharmacy stores. Other Business segment is engaged in the distribution of laboratory supplies, manufacture and distribution of chemical reagents, production and sale of pharmaceutical products.

Sector

Pharmaceuticals

Calendar

2024-06-12 - Annual General Meeting

Related indices

HONG KONG HANG SENG

More about the company

Income Statement Evolution

More financial data

Ratings for Sinopharm Group Co. Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

18.68 CNY

Average target price

24.75 CNY

Spread / Average Target

+32.46%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
SINOPHARM GROUP CO. LTD.	-1.22%	8.59B
MCKESSON CORPORATION	+15.79%	71.39B
CARDINAL HEALTH, INC.	+2.09%	25.1B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+7.95%	8.19B
HUADONG MEDICINE CO., LTD	-20.48%	7.91B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+15.26%	4.31B
EBOS GROUP LIMITED	-1.24%	3.93B
GALENICA AG	-3.02%	3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+21.10%	3.64B
MEDIPAL HOLDINGS CORPORATION	+7.96%	3.29B

Pharmaceuticals Wholesale